SPINK4: A Potential Drug Target and Biomarker (G27290)

Target Name: SPINK4

NCBI ID: G27290

SPINK4: A Potential Drug Target and Biomarker

SPINK4 (Serine Peptidase Inhibitor Kazal Type 4) is a protein that is expressed in various tissues and cells in the human body. It is a member of the SPINK4 family, which is known for its role in regulating proteasome-mediated protein degradation. The SPINK4 gene has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

SPINK4 has been shown to play a crucial role in the regulation of protein homeostasis, which is the balance between the levels of protein synthesis and degradation in cells. This is important for maintaining the stability and diversity of proteins, which are essential for many cellular functions. The SPINK4 protein has been shown to interact with various protein partners, including other SPINK4s, caseins, and chaperones.

SPINK4 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of cancer. For example, SPINK4 has been shown to promote the growth and survival of cancer cells, and it has been shown to contribute to the development of resistance to chemotherapy in cancer cells.

SPINK4 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases. For example, SPINK4 has been shown to contribute to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

SPINK4 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of autoimmune disorders. For example, SPINK4 has been shown to contribute to the development of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the liver, such as viral hepatitis and nonalcoholic steatohepatitis.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the cardiovascular system, such as heart failure and hypertension.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the immune system, such as HIV infection and cancer.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the eye, such as age-related macular degeneration and diabetic retinopathy.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the skin, such as dermatitis and psoriasis.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the gut, such as inflammatory bowel disease and gastroesophageal reflux disease.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the brain, such as neuropsychiatric diseases and neurodegenerative diseases.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the heart, such as heart failure and hypertension.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the kidneys, such as chronic kidney disease and end-stage renal disease.

SPINK4 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases that affect the liver, such as viral hepatitis and nonalcoholic steatohepatitis.

SPINK4 has also been shown to play a role in the regulation of cellular processes

Protein Name: Serine Peptidase Inhibitor Kazal Type 4

More Common Targets